Ross Muken

Stock Analyst at Evercore ISI Group

(2.17)
# 2,584
Out of 4,767 analysts
44
Total ratings
57.14%
Success rate
2.58%
Average return

Stocks Rated by Ross Muken

Charles River Laboratories International
Nov 7, 2024
Maintains: In-Line
Price Target: $190$225
Current: $171.04
Upside: +31.55%
Patterson Companies
Oct 8, 2024
Maintains: In-Line
Price Target: $23$22
Current: $31.14
Upside: -29.35%
ICON Public Limited Company
Oct 8, 2024
Maintains: Outperform
Price Target: $360$350
Current: $184.58
Upside: +89.62%
Henry Schein
Oct 8, 2024
Maintains: In-Line
Price Target: $70$74
Current: $70.58
Upside: +4.85%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126$130
Current: $121.18
Upside: +7.28%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $39.48
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $128.00
Upside: -47.66%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $85.60
Upside: +192.06%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $522.05
Upside: -57.86%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $14.97
Upside: -